Open AccessConversion to Sirolimus as Primary Immunosuppression Attenuates the Progression of Allograft Vasculopathy After Cardiac Transplantation
Author(s) -
Eugenia Raichlin,
JangHo Bae,
Zain Khalpey,
Brooks S. Edwards,
Walter K. Kremers,
Alfredo L. Clavell,
Richard J. Rodeheffer,
Robert P. Frantz,
Charanjit S. Rihal,
Amir Lerman,
Sudhir S. Kushwaha
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.692996
Subject(s) - medicine , calcineurin , transplantation , immunosuppression , urology , heart transplantation , sirolimus , azathioprine , gastroenterology , surgery , cardiology , disease
We investigated the potential of conversion to sirolimus (SRL) as a primary immunosuppressant in attenuating cardiac allograft vasculopathy progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom